Archer Materials Limited · ASX:AXE
Archer Materials — Investor Presentation (March 2021)
29 slides from Archer Materials's investor presentation, Mar 25, 2021

Slide 1: TechKnow Conference Dec
TechKnow Conference Dec 200 Research & Prototype Foundry Archer operates in, Sydney, Australia.

Slide 2: Archer is one of only a few companies building a quantum computing processor
ARCHER IS ONE OF ONLY A FEW COMPANIES IN THE WORLD BUILDING A QUANTUM COMPUTING PROCESSOR 2

Slide 3: Company Overview
/ Company Overview Archer is a technology company. The Company’s core business is in developing and commercialising innovative deep tech, including quantum computing and biotech. Archer is long-term value driven and creates maximum value by†: + Progressing its world-first technology development, inc

Slide 4: Archer staff, affiliates, materials, technology, and laboratories
Archer staff, affiliates, materials, technology, and 4 laboratories.

Slide 5: Experienced Board and Management
/ Experienced Board and Management 5

Slide 6: Quantum Computing is Revolutionary
QUANTUM COMPUTING IS REVOLUTIONARY DEEP-TECH 6

Slide 7: Classical Computing vs. Quantum Computing
/ Classical Computing vs. Quantum Computing 7

Slide 8: Innovation and Leadership
/ Innovation and Leadership Archer’s 12CQ development is led by: Dr Mohammad Choucair FRACI FRSN GAICD. Archer CEO since Dec 2017. PhD in Chemistry (UNSW). Alumni of AGSM UNSW Business School. Former World Economic Forum Global Councillor. Inventor of the 12CQ quantum computing technology. RACI Corn

Slide 9: Quantum Computing at the Edge
Archer staff and affiliates working in semiconductor chip foundry facilities. / Quantum Computing at the Edge Archer is in the pre-market development stage of building an operational quantum computing qubit processor chip (12CQ®): + Archer is currently building and testing the qubit control componen

Slide 10: Unique Technological Advantage
/ Unique Technological Advantage Electron-spin qubits in Archer’s carbon nanomaterial are one of the most promising solutions to the widespread use of quantum computing powered mobile devices: + Archer uses a qubit material with the proven potential to enable chip operation at room-temperature and i

Slide 11: Era of Quantum Computing
Hallmarks of the computing industry. / Era of Quantum Computing According to BCG† and Goldman Sachs‡, value for investors in the multi-billion dollar quantum computing economy is expected to increase rapidly as the commercial viability of quantum hardware matures: + The CSIRO§ reported Australian qu

Slide 12: The World is Data and Mobile Centric
/ The World is Data and Mobile Centric According to BCG†, a growing number of financial institutions are positioning themselves for a quantum future: + US$70 billion ($95 billion) opportunity for additional income for banks and other financial-services companies. + Quantum computing can solve proble

Slide 13: Global Partnerships
/ Global Partnerships Archer entered into an agreement with IBM to collaborate on the advancement of quantum computing, supporting: + Archer’s plans to use Qiskit as the software stack for 12CQ® processors and to participate in the global IBM Q Network†. + The Company’s access to the IBM Quantum Com

Slide 14: Unlocking Commercialisation
/ Unlocking Commercialisation Archer has made rapid, internationally recognised progress building the 12CQ® chip over the past year, towards a viable qubit processor chip technology: + Archer has commercial access to prototyping chip foundries (Australia & Switzerland), and established collaborative

Slide 15: Well Protected IP is Characteristic of Successful Deep Techs
WELL PROTECTED IP IS CHARACTERISTIC OF SUCCESSFUL DEEP TECHS 15

Slide 16: Global Competitive Advantage
/ Global Competitive Advantage As of 1 March 2021. 16

Slide 17: Archer is Building Advanced Semiconductor Devices
ARCHER IS BUILDING ADVANCED SEMICONDUCTOR DEVICES 17

Slide 18: Lab-on-a-Chip Diagnostics
/ Lab-on-a-Chip Diagnostics *More information on Australian regulations related to IVDs: https://www.tga.gov.au/medical-devices-ivds 18

Slide 19: Lab-on-a-Chip Tech is a Paradigm Shift in Medical Diagnostics
LAB-ON-A-CHIP TECH IS A PARADIGM SHIFT IN MEDICAL DIAGNOSTICS 19

Slide 20: Building a Biochip
/ Building a Biochip Archer is in the early stages of building a graphene based lab-on-a-chip device (A1 Biochip™): + Archer owns IP to commercialise the only reported graphene materials capable of stable and robust selective hierarchal chemistries compatible to the single molecule level⨍. + Microfl

Slide 21: Significant Socio-economic Impacts
/ Significant Socio-economic Impacts The A1 Biochip™ end-use is initially aimed at the complex detection of diseases affecting the respiratory system, as they remain one of the world’s most deadly communicable diseases†: + Archer works with a German Biotech partner†† to determine potential candidate

Slide 22: Nanofabrication is a Prerequisite
/ Nanofabrication is a Prerequisite Archer has made rapid progress over the past 6-12 months towards building the A1 Biochip™, and is now able to miniaturise its biosensing processes to chip-formats, a key barrier to commercialising lab-on-a-chip devices†: + Successfully demonstrated fabrication of

Slide 23: Graphene Impact on Biotechnology
/ Graphene Impact on Biotechnology ^ # Nature Commun., 9, 1577 (2018) *Nature Biomed. Eng., 3, 427–437 (2019) npj Clean Water, 1, 5 (2018) **Nature Nanotech., 11, 127–136 (2016) ***Int. J. Nanomedicine, 14, 5753–5783 (2019) ^^Sci. Rep., 9, 19311 (2019) 23

Slide 24: High-value Graphene Materials
/ High-value Graphene Materials Archer’s biochip design principles involve using proprietary graphene-based materials as integrated circuits, to form the key sensing elements in its biochip: + Graphene1 has a combination of exceptional materials’ properties that could make it useful and valuable2. +

Slide 25: The Global Value Chain in Commercialising Deep Tech is Growing
THE GLOBAL VALUE CHAIN IN COMMERCIALISING DEEP TECH IS GROWING 25

Slide 26: Archer's Accelerated Advance
/ Archer’s Accelerated Advance Over the next 12 months key aspects of the Company’s strategy involves: + Progressing the Company’s deep-tech development with a focus on high-value added milestones in the operation of the 12CQ® chip & nanofabrication of the A1 Biochip™. + Advancing with international

Slide 27: Contact details
The Board of Archer authorised this announcement to be given to ASX. ASX Code: AXE ACN: 123 993 233 ADELAIDE SYDNEY Ground Floor, 28 Greenhill Road Level 4, 17-19 Bridge Street Wayville SA 5034 Australia Sydney NSW 2000 Australia Phone: +61 8 8272 3288 Phone: +61 2 8091 3240 Email: hello@archerx.com

Slide 28: Appendices: Board and Executive Management
Appendices Board and Executive Management (Slide 5) Greg English LLB, BE (Mining) Greg English is the co-founder and Executive Chairman of Archer. He has been Chairman of the board since Executive Chairman 2008 and has overseen Archer’s transition from a South Australian focussed minerals exploratio

Slide 29: Appendices: Board and Executive Management
Appendices Board and Executive Management (Slide 5) Mohammad Choucair PhD, FRACI FRSN GAICD Dr Mohammad Choucair was appointed Chief Executive Officer on 1st December 2017. Dr Choucair is Chief Executive Officer alumni of the AGSM UNSW Business School and has a deep-tech background in nanotechnology
Source: Internet Archive copy of archerx.com.au
More decks from Archer Materials Limited
Shareholder Meeting (November 2026)20 slides · Nov 20, 2026
15th Annual Australian Microcap Investment Conference 202619 slides · Oct 16, 2026
Investor Presentation (July 2026)32 slides · Jul 3, 2026
H1 FY2026 Earnings Presentation11 slides · Mar 4, 2026
Investor Presentation (January 2026)10 slides · Jan 29, 2026
Shareholder Meeting (November 2025)18 slides · Nov 20, 2025